Antiparasitic chemotherapy: from genomes to mechanisms

David Horn, Manoj T. Duraisingh

    Research output: Contribution to journalArticlepeer-review

    47 Citations (Scopus)


    Owing to the absence of antiparasitic vaccines and the constant threat of drug resistance, the development of novel antiparasitic chemotherapies remains of major importance for disease control. A better understanding of drug transport (uptake and efflux), drug metabolism and the identification of drug targets, and mechanisms of drug resistance would facilitate the development of more effective therapies. Here, we focus on malaria and African trypanosomiasis. We review existing drugs and drug development, emphasizing high-throughput genomic and genetic approaches, which hold great promise for elucidating antiparasitic mechanisms. We describe the approaches and technologies that have been influential for each parasite and develop new ideas for future research directions, including mode-of-action studies for drug target deconvolution.
    Original languageEnglish
    Pages (from-to)71-94
    Number of pages24
    JournalAnnual Review of Pharmacology and Toxicology
    Early online date11 Sept 2013
    Publication statusPublished - Jan 2014


    Dive into the research topics of 'Antiparasitic chemotherapy: from genomes to mechanisms'. Together they form a unique fingerprint.

    Cite this